Manager, End User Services & Lab Support
Genetix Biotherapeutics
Manager, End User Services & Lab Support
Genetix Biotherapeutics
Develops and commercializes autologous gene therapies
About Genetix Biotherapeutics
At Genetix Biotherapeutics every role has meaning, every team member is respected, and every day is a chance to make a difference. When you join Genetix, you're not just landing a new role, you become part of a company that's pursuing curative gene therapies to give patients and their families more days. We are doers, thinkers and collaborators who embrace and live by our values:
Our innovation is rooted in the diversity of our teams and results are achieved through cooperation and the integration of multiple viewpoints. This is personal and we approach every challenge with radical care.
This is a full-time position (5 days a week) at our lab facility and HQ located at Assembly Row, Somerville, MA.
SUMMARY
The Manager, End User Services & Lab Support will own the end-to-end experience that keeps Genetix employees and laboratories productive — from front-line break/fix support and service ticket management to the day-to-day administration of the core platforms our workforce relies on. This role is both a hands-on service leader and a platform owner, responsible for the quality, responsiveness, and continuous improvement of IT support across our Somerville – Assembly Row and Hatch Bio sites.
This role will serve as the primary owner of end user services, setting the standard for how support is delivered, how tickets are triaged and resolved against service levels, and how employees are onboarded and offboarded. Because a significant portion of our user base works at the bench, the Manager will also be responsible for supporting laboratory computing and instrumentation — making direct lab experience essential to success in this role.
The ideal candidate is an experienced end user services or IT service desk leader who is equally comfortable resolving a break/fix ticket, administering key platforms such as Microsoft 365 and DocuSign, and building the processes and metrics that raise the bar on service delivery — all within a fast-paced, regulated biotech environment.
RESPONSIBILITIES
End User Services & Support Delivery
Platform Administration & Ownership
User Onboarding & Offboarding
Lab Support & Systems
Team & Business Partnership
QUALIFICATIONS
Required
Preferred
Additional Information
The pay transparency range provided below is based on what we believe is a reasonable estimate for the base salary pay range for this job at the time of posting. We may ultimately pay more or less than the posted range, and the range may be modified in the future. This role is eligible for an annual bonus and long-term incentive. Actual base salary pay will be based on several factors, including but not limited to experience, skills, relevant education/qualifications, external market, internal equity, and other job-related factors permitted by law.
Genetix’s total rewards package also provides employees with a comprehensive and competitive benefits suite to support a variety of employee needs. These benefits include comprehensive health, life and disability insurance, employer-matched 401(k) plan, lifestyle spending account, flexible time-off + paid holidays and winter holiday period, tuition reimbursement & loan repayment assistance, paid parental leave, paid onsite parking, commuter subsidy, and much more.
Genetix is proud to be an equal opportunity employer, seeking to create a welcoming and diverse environment. All applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, veteran status or any other applicable legally protected characteristics.
Pay Transparency 135000 - 165000 USD
Develops and commercializes autologous gene therapies
Genetix Biotherapeutics develops autologous gene therapies using a lentiviral vector to insert a correct gene into a patient’s own blood stem cells, then re-infuses the cells to treat the underlying disease. It has three FDA-approved products: LYFGENIA for sickle cell disease, ZYNTEGLO for transfusion-dependent β-thalassemia, and SKYSONA for cerebral adrenoleukodystrophy. The company differentiates itself by using an established LVV-based platform and by expanding manufacturing capacity and access through partnerships with Qualified Treatment Centers. Its goal is to provide durable, curative treatments for genetic disorders and to broaden global patient access to these therapies.
Explore more opportunities at Genetix Biotherapeutics